A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2‐Positive Metastatic Breast Cancer (CCTG IND.229)
The Oncologist is a journal devoted to medical and practice issues for surgical, radiation, and medical oncologists.
Related Articles
Phase Ib/II trial of talimogene laherparepvec alone and with pembrolizumab in advanced solid tumors with liver metastases and hepatocellular carcinoma
This study is the first investigation of intrahepatic T-VEC injection in patients with liver lesions due to metastatic solid tumors or hepatocellular carci
Frequency and outcomes of BRAF alterations identified by liquid biopsy in metastatic, non-colorectal gastrointestinal cancers
AbstractBackground. Impact of BRAF V600E mutations (BRAFV600E), a poor prognostic factor in metastatic colorectal cancer, is lacking in non-CRC gastrointes
Pancreatic enzyme replacement therapy in advanced adenocarcinoma of the pancreas improved overall survival: a retrospective, single institution study
AbstractBackground. Weight loss and exocrine pancreatic insufficiency are common in advanced pancreatic ductal adenocarcinoma (PDAC) and are associated wit
Early phase trials: the perils of nonpublication
In a recent article published in The Oncologist, a group of Phase I trialists dissect the problem of publication (or lack thereof) for early phase…
Medical accuracy of artificial intelligence chatbots in oncology: a scoping review
AbstractBackground. Recent advances in large language models (LLM) have enabled human-like qualities of natural language competency. Applied to oncology, L
Clinical and pathological outcomes of deferred nephrectomy in patients with metastatic and locally advanced RCC after immune checkpoint inhibitors
AbstractBackground and objective. Cytoreductive nephrectomy following immune checkpoint blockade (ICB) in metastatic renal cell carcinoma remains controver
Treatment patterns and associated outcomes among patients with HER2+ metastatic breast cancer in the United States: an observational cohort study
With the expanding treatment options for HER2+ metastatic breast cancer, updated assessments of contemporary treatment patterns and clinical outcomes are n
Liver transplantation for colorectal cancer with liver metastases
Abstract. Over the last decade, multiple clinical trials have demonstrated a survival benefit for liver transplantation in colorectal cancer with liver met
Primum succurrere; first hasten to help
One of the first things we are taught in medical school is the well-known injunction “primum non nocere” or “first do no harm.” While this…
Outcomes for recurrent or metastatic head and neck cancer by HPV status: a systematic review and meta-analysis
AbstractBackground. Human papillomavirus (HPV)-positive (HPV+) recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) exhibits distinct